Fig. 3

Alteration in AST and ALT levels pre-, 6, and 12 months post-SGLT2i or DPP4i treatment. Data are presented as the mean ± SD. The Mann–Whitney U-test was used to compare eGFR values pre- and 12 months post-SGLT2i or DPP4i treatment